Results 151 to 160 of about 10,808 (171)
Some of the next articles are maybe not open access.

Vathasura Kudineer, an Andrographis based polyherbal formulation exhibits immunomodulation and inhibits chikungunya virus (CHIKV) under in vitro conditions

Journal of Ethnopharmacology, 2023
Chikungunya disease (CHIKD) is caused by the alphavirus, chikungunya virus (CHIKV) and is characterized by acute fever and joint inflammation; the inflammation continues even after clearance of the virus from the system, persisting for several months to years. Currently, there are no modern medicines/vaccines available for its treatment and use of over-
Abdul Hasan   +6 more
openaire   +2 more sources

Diagnosing the Outbreak and Spread of the Chikungunya Virus in Central & South America - The DARPA CHIKV Challenge

Journal of Clinical and Biomedical Advances, 2023
In 2014, the U.S. Defense Advanced Research Projects Agency (DARPA) issued a “challenge” to forecast the future outbreaks and spreads of the virus Chikungunya Virus (CHIKV) in Central and South America. We took on the challenge of predicting the cumulative number of Pacific Atlantic Health Organization (PAHO) reported Chikungunya or CHIKV cases by ...
openaire   +1 more source

Chikungunya virus (CHIKV): What can be expected after the acute phase?

Reumatología Clínica (English Edition), 2016
Vianna J, Khoury, Pablo R, Camilo
openaire   +2 more sources

Chikungunya Virus (CHIKV) Pathogenesis: From Acute Fever to Chronic Arthritis—Immune Mechanisms and Therapeutic Implications

Current Topics in Medicinal Chemistry
Chikungunya Virus (CHIKV) is an arthropod-borne alphavirus that represents a substantial worldwide health burden. A percentage of patients go on to suffer from Chronic Chikungunya Arthritis (CCA) that lasts for months, or even years, and causes disability.
Dongbing Li, Guizhen Lyu
openaire   +1 more source

EPH160 Burden of Illness (BOI) and Paucity of Treatment of the Mosquito-Borne Chikungunya Virus (CHIKV)

Value in Health, 2022
K Bakker   +4 more
openaire   +1 more source

Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis

Virologica Sinica, 2019
Jihyun Yang   +2 more
exaly  

Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus

Vaccine, 2008
Kar Muthumani   +2 more
exaly  

Home - About - Disclaimer - Privacy